Understanding Cancer Grade

Tumor grade describes how abnormal cancer cells look under a microscope. It is different from stage, which describes size and spread. Grade gives your doctor a clue about how fast the cancer is likely to grow. Lower grades tend to grow slower. Higher grades tend to grow faster.

Most cancers use a scale from grade 1 to grade 4.

• Grade 1, well differentiated: Cells look close to normal. The cancer tends to grow slowly.
• Grade 2, moderately differentiated: Cells look somewhat abnormal. Growth is intermediate.
• Grade 3, poorly differentiated: Cells look quite abnormal. The cancer tends to grow faster.
• Grade 4, undifferentiated: Cells look the most abnormal. This usually means the fastest growth.
• Grade X: The grade could not be determined from the sample.

A pathologist assigns the grade after examining tissue from a biopsy or surgery under a microscope. They look at how closely the cancer cells resemble normal, healthy cells from that organ.

People often mix these up, but they measure separate things. Grade is about how the cells look and behave. Stage is about how big the cancer is, and how far it has spread. A cancer can be low grade but high stage, or high grade but low stage. Your doctor uses both together, along with other information, to plan your treatment.

A higher-grade cancer may call for more aggressive treatment sooner, since it is more likely to grow or spread quickly. A lower-grade cancer sometimes allows for a less intense approach, or even watching closely before starting treatment, depending on the cancer type. Grade is one factor among several. Your age, overall health, the exact cancer type, and specific genetic features of the tumor all factor into the final plan too.

Some cancers use their own specific grading systems, built around what matters most for that particular disease. Prostate cancer uses the Gleason score. Breast cancer uses the Nottingham grading system. These systems still follow the same basic idea: how abnormal do the cells look, and what does that suggest about how the cancer will behave. If your pathology report uses an unfamiliar scoring system, ask your doctor to translate it into the standard grade 1 through 4 framework, so you have something to compare it against.

Your grade is listed on your pathology report, the document written after a biopsy or surgery. It is sometimes shown as a number, like "grade 2," and sometimes as a score within a cancer-specific system, like a Gleason score of 7. If you have a copy of your pathology report, look for a section labeled "grade," "differentiation," or the name of a specific scoring system. If you cannot find it, or the wording is confusing, ask your doctor's office for a plain-language summary.

For some cancers, a higher grade prompts additional genetic or molecular testing on the tumor, since faster-growing cancers are more likely to be tested for specific targetable changes. This connects grade to decisions about targeted therapy or immunotherapy, not just to how urgently treatment should start. Ask whether your grade played a role in which additional tests were ordered on your tumor tissue.

Grade estimates likely behavior. It does not predict your individual outcome with certainty. Two people with the same grade of the same cancer can respond very differently to the same treatment. Grade is one useful piece of information among many, not a fixed forecast. Try to hold it loosely while your team builds a full picture from every test result together.

Ask what grade your cancer is, and what that means for how it is likely to behave. Ask how grade factored into your specific treatment recommendation. Ask whether your cancer type uses a special grading system, and what your score means within it. Ask how grade and stage together shape your prognosis, since neither one alone tells the full story.

• National Cancer Institute — Tumor Grade.